These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1166 related articles for article (PubMed ID: 28900998)
21. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma? Shim YM; Park JS; Lee M; Kim D; Kim K Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487 [TBL] [Abstract][Full Text] [Related]
22. Survival risk prediction model for patients with pT Qi Z; Hu Y; Qiu R; Li J; Li Y; He M; Wang Y J Cardiothorac Surg; 2021 May; 16(1):121. PubMed ID: 33933129 [TBL] [Abstract][Full Text] [Related]
23. Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor. Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Shigaki H; Yamaguchi T Ann Surg Oncol; 2014 May; 21(5):1596-601. PubMed ID: 24531703 [TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA SPRY4-IT1 as a promising indicator for three field lymph-node dissection of thoracic esophageal carcinoma. Qie P; Yin Q; Xun X; Song Y; Zhou S; Liu H; Feng J; Tian Z J Cardiothorac Surg; 2021 Mar; 16(1):48. PubMed ID: 33757566 [TBL] [Abstract][Full Text] [Related]
25. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer. Morimoto J; Tanaka H; Ohira M; Kubo N; Muguruma K; Sakurai K; Yamashita Y; Maeda K; Sawada T; Hirakawa K Dis Esophagus; 2014 Jan; 27(1):63-71. PubMed ID: 23480452 [TBL] [Abstract][Full Text] [Related]
26. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma. Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154 [TBL] [Abstract][Full Text] [Related]
27. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma]. Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083 [TBL] [Abstract][Full Text] [Related]
28. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience. Lin G; Liu H; Li J J Cardiothorac Surg; 2019 Mar; 14(1):58. PubMed ID: 30866983 [TBL] [Abstract][Full Text] [Related]
29. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. Chen G; Wang Z; Liu XY; Liu FY World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905 [TBL] [Abstract][Full Text] [Related]
30. Primary mucoepidermoid carcinoma of the esophagus. Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086 [TBL] [Abstract][Full Text] [Related]
31. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study. Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907 [TBL] [Abstract][Full Text] [Related]
32. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma]. Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865 [TBL] [Abstract][Full Text] [Related]
33. Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence. Xu ZC; Su BA; Li JC; Cheng WF; Chen J Cancer Radiother; 2023 May; 27(3):189-195. PubMed ID: 36754752 [TBL] [Abstract][Full Text] [Related]
34. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus]. Wu J; Chai Y; Zhou XM; Chen QX; Yan FL Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797 [TBL] [Abstract][Full Text] [Related]
35. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases]. Chen G; Wang Z; Liu XY; Liu FY Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760 [TBL] [Abstract][Full Text] [Related]
36. Factors on prognosis in patients of stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy. Wang Y; Wang L; Yang Q; Li J; Qi Z; He M; Yao J; Qiao X J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C16-23. PubMed ID: 26323918 [TBL] [Abstract][Full Text] [Related]
37. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy. Li H; Zhang Y; Cai H; Xiang J Eur Surg Res; 2007; 39(1):1-6. PubMed ID: 17106199 [TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma? Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079 [TBL] [Abstract][Full Text] [Related]
39. [Prognostic influence of preoperative Nutritional Risk Screening -2002 (NRS-2002) score for patients with thoracic esophageal squamous cell carcinoma receiving surgery]. Sun HJ; Guo XW; Ji SJ; Zhou SB; Gu L Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):917-921. PubMed ID: 30605983 [No Abstract] [Full Text] [Related]
40. Explore the radiotherapeutic clinical target volume delineation for thoracic esophageal squamous cell carcinoma from the pattern of lymphatic metastases. Cheng J; Kong L; Huang W; Li B; Li H; Wang Z; Zhang J; Zhou T; Sun H J Thorac Oncol; 2013 Mar; 8(3):359-65. PubMed ID: 23263689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]